| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $234K | +22.5% | +118.7% |
| Cost of Revenue | $0 | -100.0% | -100.0% |
| Gross Profit | $234K | +23.8% | +470.7% |
| R&D Expense | $2.3M | +6.2% | +5.6% |
| SG&A Expense | $4.2M | +5.4% | -23.5% |
| Operating Income | -$6.2M | -5.1% | +17.7% |
| Net Income | -$11.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $670K | +407.6% | -16.0% |
| Accounts Receivable | $0 | -100.0% | — |
| Current Assets | $7.1M | +65.4% | +30.8% |
| Total Assets | $19.6M | +113.2% | +39.0% |
| Current Liabilities | $17.3M | -8.7% | +23.5% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.7M | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $11.8M | — | — |
| -71.7% |
| -42.7% |
| EPS (Basic) | -$1.08 | +12.2% | -140.0% |
| EPS (Diluted) | -$1.08 | +12.2% | -140.0% |
| $20.3M |
| +5.9% |
| +4.0% |
| Stockholders' Equity | -$694K | +93.0% | +87.2% |